General Information of the Compound
| Compound ID |
CP0689759
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-(5-{4-[(10-Hydroxy-14-methyl-5-oxo-5,7,8,13,13b,14-hexahydro-indolo[2',3':3,4]pyrido[2,1-b]quinazolin-3-ylamino)-methyl]-phenyl}-[1,3,4]oxadiazol-2-yl)-pentanoic acid hydroxyamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C33H33N7O5
|
||||||||||||||||||
| Molecular Weight |
607.671
|
||||||||||||||||||
| Canonical SMILES |
CN1c2ccc(NCc3ccc(-c4nnc(CCCCC(=O)NO)o4)cc3)cc2C(=O)N2CCc3c([nH]c4ccc(O)cc34)C21
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C33H33N7O5/c1-39-27-13-10-21(16-25(27)33(43)40-15-14-23-24-17-22(41)11-12-26(24)35-30(23)32(39)40)34-18-19-6-8-20(9-7-19)31-37-36-29(45-31)5-3-2-4-28(42)38-44/h6-13,16-17,32,34-35,41,44H,2-5,14-15,18H2,1H3,(H,38,42)
Show/Hide
|
||||||||||||||||||
| InChIKey |
YYARBGNAYGPNNS-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound